A Mechanistic Study to Assess a Single Dose of CYB003 in Participants With Depression and Anxiety

Recruiting

Phase 2

PsilocybinA Mechanistic Study to Assess a Single Dose of CYB003 in Participants With Depression and Anxiety

Sponsor:

Ohio State University

Code:

NCT06820723

Conditions

Depression

Anxiety

Major Depressive Disorder

Eligibility Criteria

Sex: All

Age: 21 - 65

Healthy Volunteers: Not accepted

Interventions

CYB003

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-15. This information was provided to ClinicalTrials.gov by Ohio State University on 2026-07-23.